2004 Annual Meeting | Frontiers in Clinical Neuroscience: Beyond the Decade of the Brain Plenary Session
| 09:00 AM - 11:00 AM |
Molecular Basis of Muscular Dystrophy
Kevin P. Campbell, PhD |
|
| 09:00 AM - 11:00 AM |
The Emerging Importance of RNA Regulation in Neurological Disease: Its Role in Paraneoplastic Syndromes and Fragile-X Mental Retardation
Robert B. Darnell, MD, PhD |
|
| 09:00 AM - 11:00 AM |
What Can Chemokines Do To (and for) My Patients?
Richard M. Ransohoff, MD |
|
| 09:00 AM - 11:00 AM |
Markers and Mediators of Neuronal Deficits in Dementia
Lennart Mucke, MD |
| Richard M. Ransohoff, MD | Dr. Ransohoff has received personal compensation for serving as an employee of Third Rock Ventures. Dr. Ransohoff has stock in Biogen. Dr. Ransohoff has received intellectual property interests from a discovery or technology relating to health care. |
| Lennart Mucke, MD | No disclosure on file |
| Kevin P. Campbell, PhD | No disclosure on file |
| Robert B. Darnell, MD, PhD | Dr. Darnell has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Atreca, Inc.. Dr. Darnell has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for MITRE. Dr. Darnell has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for OPNA. |